Literature DB >> 31432151

Oncological role of HMGA2 (Review).

Shizhen Zhang1, Qiuping Mo2, Xiaochen Wang1.   

Abstract

The high mobility group A2 (HMGA2) protein is a non‑histone architectural transcription factor that modulates the transcription of several genes by binding to AT‑rich sequences in the minor groove of B‑form DNA and alters the chromatin structure. As a result, HMGA2 influences a variety of biological processes, including the cell cycle process, DNA damage repair process, apoptosis, senescence, epithelial‑mesenchymal transition and telomere restoration. In addition, the overexpression of HMGA2 is a feature of malignancy, and its elevated expression in human cancer predicts the efficacy of certain chemotherapeutic agents. Accumulating evidence has suggested that the detection of HMGA2 can be used as a routine procedure in clinical tumour analysis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31432151     DOI: 10.3892/ijo.2019.4856

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  42 in total

1.  Circular RNA CircSHKBP1 accelerates the proliferation, invasion, angiogenesis, and stem cell-like properties via modulation of microR-766-5p/high mobility group AT-hook 2 axis in laryngeal squamous cell carcinoma.

Authors:  Fu Chen; Haiyan Zhang; Jie Wang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Circ_0020123 promotes NSCLC tumorigenesis via up-regulating KIAA1522 expression through miR-940.

Authors:  Yihui Fan; Qing Wang; Minxin Shi; Guanjun Ju; Haimin Lu; Liyun Zheng; Jian Chen; Xiaomei Zhou; Ting Xiao; Saihua Chen
Journal:  Cell Cycle       Date:  2022-02-23       Impact factor: 5.173

3.  RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation.

Authors:  Masumi Wada; Yusuke Goto; Takako Tanaka; Reona Okada; Shogo Moriya; Tetsuya Idichi; Masahiro Noda; Ken Sasaki; Yoshiaki Kita; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe; Naohiko Seki
Journal:  J Hum Genet       Date:  2020-07-04       Impact factor: 3.172

4.  Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.

Authors:  Rui Xu; Shiwu Yin; Meng Zheng; Xiaohong Pei; Xuebing Ji
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

5.  Prioritization of Osteoporosis-Associated Genome-wide Association Study (GWAS) Single-Nucleotide Polymorphisms (SNPs) Using Epigenomics and Transcriptomics.

Authors:  Xiao Zhang; Hong-Wen Deng; Hui Shen; Melanie Ehrlich
Journal:  JBMR Plus       Date:  2021-03-19

6.  CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis.

Authors:  Mingzhi Zhu; Yanyan Wang; Fang Wang; Lin Li; Xinguang Qiu
Journal:  Cancer Cell Int       Date:  2021-07-19       Impact factor: 5.722

Review 7.  Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions.

Authors:  Liliana Montella; Lucia Altucci; Federica Sarno; Carlo Buonerba; Stefano De Simone; Bianca Arianna Facchini; Elisena Franzese; Ferdinando De Vita; Salvatore Tafuto; Massimiliano Berretta; Gaetano Facchini
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

8.  Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children.

Authors:  Jingying Zhou; Pan Wang; Ran Zhang; Xiaokai Huang; Hanqi Dai; Li Yuan; Jichen Ruan
Journal:  Pharmgenomics Pers Med       Date:  2021-05-25

Review 9.  HMGA1 Is a Potential Driver of Preeclampsia Pathogenesis by Interference with Extravillous Trophoblasts Invasion.

Authors:  Keiichi Matsubara; Yuko Matsubara; Yuka Uchikura; Katsuko Takagi; Akiko Yano; Takashi Sugiyama
Journal:  Biomolecules       Date:  2021-05-31

10.  Silencing of HMGA2 by siRNA Loaded Methotrexate Functionalized Polyamidoamine Dendrimer for Human Breast Cancer Cell Therapy.

Authors:  Fereydoon Abedi Gaballu; William Chi-Shing Cho; Gholamreza Dehghan; Amir Zarebkohan; Behzad Baradaran; Behzad Mansoori; Soheil Abbaspour-Ravasjani; Ali Mohammadi; Nader Sheibani; Ayuob Aghanejad; Jafar Ezzati Nazhad Dolatabadi
Journal:  Genes (Basel)       Date:  2021-07-20       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.